Live in the NASDAQ market site in the heart of New York City's Times Square.

This is fast money. Here's what's on tap tonight.

China and earnings and inflation. Oh my, a site of potential market moving events

on the calendar for next week and everything

from semis to shopping could feel the impact, how you should set yourself up heading into the weekend.

Plus, bad medicine, while Eli Lillian Novo Nordis seemed to hit one new high after another.

Pfizer shares are at multi-year lows.

Is there more pain ahead for this name?

The Chart Masters got some answers.

And later, unplugged shares of EV battery maker

plug power, seeing their worst day since 2014.

Can the one-time standout stock get recharge or has it lost with spark?

We'll dive into the options pits to find out.

I'm Melissa Lee Kumbi-Lack from Studio B at the Nasak on the

Desinite Tim Seymour, Karen Finner, and Fano and Eisen and Guy Adami.

We start off with some breaking news out of Moody's, the ratings agency just cutting

the outlook for the US to negative from stable analysts saying

downside risks to the country's fiscal strength have increased. They did

though however reaffirm the US's AAA rating, it's the only rating agency with that rating.

U.S. Deputy Treasury Secretary Wally Ademo, responding, saying,

we disagree with the shift the American economy remains strong,

and Treasury securities are the world's preeminent,

...